Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar.

We report the results of clinical studies carried out at six sites in Madagascar, between January and October 2006. The aims were (i) to update our knowledge of the burden of Plasmodium malariae infection and (ii) to assess the therapeutic efficacy of chloroquine for uncomplicated quartan malaria. Our findings confirm that P. malariae is the third leading cause of malaria, accounting for 1.1% of all malarial infections. They also demonstrate that chloroquine-currently recommended for the home management of presumed malaria in children under the age of five years and commonly used by adults-remains highly effective in patients with uncomplicated P. malariae infection.

[1]  D. Ménard,et al.  Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar , 2007, Malaria Journal.

[2]  D. Ménard,et al.  Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar. , 2007, The American journal of tropical medicine and hygiene.

[3]  S. Krudsood,et al.  Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment. , 2006, The Korean journal of parasitology.

[4]  M. Randrianarivelojosia,et al.  Moderate transmission but high prevalence of malaria in Madagascar. , 2006, International journal for parasitology.

[5]  D. Ménard,et al.  Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children , 2006, Malaria Journal.

[6]  S. Picot,et al.  Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human blood by real-time polymerase chain reaction. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  G. Jeffery,et al.  Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine. , 2002, The American journal of tropical medicine and hygiene.

[8]  M. Bangs,et al.  Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia , 2002, The Lancet.

[9]  F. Kawamoto,et al.  How prevalent are Plasmodium ovale and P. malariae in East Asia? , 1999, Parasitology today.

[10]  C. Wongsrichanalai,et al.  High prevalence of Plasmodium malariae and Plasmodium ovale in malaria patients along the Thai‐Myanmar border, as revealed by acridine orange staining and PCR‐based diagnoses , 1998, Tropical medicine & international health : TM & IH.

[11]  C. Rogier,et al.  The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. , 1994, The American journal of tropical medicine and hygiene.

[12]  J. Kihonda,et al.  Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. , 1993, Acta tropica.

[13]  N. Sathiakumar,et al.  Clinicopathological features of childhood nephrotic syndrome in northern Nigeria. , 1990, The Quarterly journal of medicine.

[14]  W. Wernsdorfer,et al.  Malaria: Principles and Practice of Malariology , 1989 .

[15]  Mcligeyo So,et al.  Review article: immune nephritides due to malaria. , 1988 .

[16]  P. Byass,et al.  Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  J. W. Kibukamusoke.  The hazard of malarial nephropathy. , 1986, Parasitology today.

[18]  L. Molineaux,et al.  A longitudinal study of human malaria in the West African Savanna in the absence of control measures: relationships between different Plasmodium species, in particular P. falciparum and P. malariae. , 1980, The American journal of tropical medicine and hygiene.

[19]  Unicef. Nigeria Country Office.  Kenya, multiple indicator cluster survey (MICS) report, 2000 , 2003 .

[20]  J. Breman,et al.  The intolerable burden of malaria: a new look at the numbers. , 2001, The American journal of tropical medicine and hygiene.

[21]  U. d’Alessandro,et al.  Monitoring antimalarial drug resistance (report of a WHO Consultation) , 2001 .

[22]  R. Snow,et al.  Why do some African children develop severe malaria? , 1991, Parasitology today.

[23]  D. Fontenille,et al.  [Malaria in 1989 in a village in the Highland Plateaux of Madagascar. Parasitologic and clinical data obtained in a longitudinal study of a population representative of this region]. , 1990, Archives de l'Institut Pasteur de Madagascar.

[24]  P. Rabarison,et al.  [Malaria in the island of Sainte Marie in 1989. Epidemiologic, parasitologic, serologic and clinical data]. , 1990, Archives de l'Institut Pasteur de Madagascar.

[25]  L. Otieno,et al.  Review article: immune nephritides due to malaria. , 1988, East African medical journal.